Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA topoisomerases are essential enzymes that regulate the overwinding or underwinding (“supercoiling”) of double-stranded DNA. They solve critical topological problems during fundamental cellular processes such as replication, transcription, recombination, chromosome condensation/segregation, and chromatin remodeling. These enzymes function by introducing temporary single-strand breaks (type I) or double-strand breaks (type II) into the phosphodiester backbone of DNA. This allows them to relax supercoils, untangle knots/catenanes formed during replication or repair processes, and ensure proper chromosome segregation. There are two main classes—Type I enzymes cleave one strand at a time without ATP hydrolysis; Type II cleave both strands using ATP energy. Human isoforms include TOP1/TOP2A/TOP2B; bacterial forms include gyrases which introduce negative supercoils. Because their activity is vital for rapidly dividing cells—and because their inhibition leads to lethal genome damage—DNA topoisomerases are validated therapeutic targets in cancer chemotherapy and antibacterial drug development.[1][2][4][5][6]
– Inhibitors can stabilize the transient break in the DNA introduced by the enzyme, preventing religation and leading to accumulation of breaks that trigger cell death. – Some drugs act as poisons by trapping the enzyme-DNA cleavage complex; others inhibit catalytic activity or prevent binding to DNA.[6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase.